http://www.fda.gov/cder/orange/appendix_a.txt ACTHAR GEL, CORTICOTROPIN H.R.-50, HYDROCHLOROTHIAZIDE HABITROL, NICOTINE (OTC) HALCION, TRIAZOLAM HALDOL SOLUTAB, HALOPERIDOL HALDOL, HALOPERIDOL HALDOL, HALOPERIDOL DECANOATE HALDOL, HALOPERIDOL LACTATE HALDRONE, PARAMETHASONE ACETATE HALFAN, HALOFANTRINE HYDROCHLORIDE HALOG, HALCINONIDE HALOG-E, HALCINONIDE HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE HALOPERIDOL INTENSOL,...
rld_labeling_approved_may_1999 Firm Date ISUPREL Isoproterenol Hydrochloride Injection 10-515 S-022 Abbott 4-May-1999 PATINOL /PLATINOL-AQ Cisplatin For Injection/Cisplatin Injection 18-057 S-068 Bristol Myers Squibb 5-May-1999 MAXAQUIN Lomefolxacin Hydrochloride 20-013 S-013 Searle 6-May-1999 URACIL MUSTARD Uracil Mustard capsules 12-892 S-001 Roberts Labs 6-May-1999 ESTROSTEP...
FDA Drug Approvals List February 2000 - Drug Approvals for February 2000 Definitions and Notes Original New Drug Applications Original Application #: 021015 Approval Date: 28-FEB-00 Trade Name: ANDROGEL Chemical Type: 3 Therapeutic Potential: S Dosage Form: GEL Applicant: UNIMED PHARMACEUTICALS INC Active Ingredient(s): TESTOSTERONE OTC/RX Status: RX Indication(s): For replacement therapy in males for conditions...
Prescription and OTC Drug Product List 2/2000 Prescription and Over-the-Counter Drug Product List - 20th Edition Cumulative Supplement Number 2: February 2000 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; HYDROCODONE BITARTRATE CICLOPIROX TABLET; ORAL CREAM; TOPICAL LORTAB LOPROX - DLT - UCB 325MG;5MG N40099 001 - ADD - + AVENTIS PHARMS 0.77% N18748 001 - DLT - JUN 25, 1997 - ADD -...
FDA Drug Approvals List- May 1999 Efficacy Supplemental New Drug Applications Application #: 020584 Efficacy Supplement#: 003 Type: SE2 to Original New Drug Application Approval Date: 27-MAY-99 Trade Name: LODINE XL Dosage Form: TABLET, EXTENDED RELEASE Applicant: WYETH AYERST LABORATORIES INC Active Ingredient(s): ETODOLAC OTC/RX Status: RX Efficacy Claim: For the management of the signs and symptoms of...
http://www.fda.gov/cder/ogd/rld/11178s37.pdf page 3
http://www.fda.gov/cder/ogd/rld/10515s22.pdf page 2
FDA Drug Approvals List- August 1998 Active Ingredient(s): CILOSTAZOL OTC/RX Status: RX Original Application #: 020744 Approvable Date: 03-SEP-98 Trade Name: CURASURF Dosage Form: SUSPENSION Applicant: DEY LABORATORIES INC Active Ingredient(s): PORACTANT OTC/RX Status: RX Original Application #: 020746 Approvable Date: 02-SEP-98 Trade Name: RHINOCORT AQUA NASAL SPRAY Dosage Form: SPRAY, METERED Applicant: ASTRA USA INC...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, GANTANOL to LYSODREN Trade Names of Some Commonly Used Drugs TRADE AND GENERIC NAMES OF COMMONLY USED DRUGS GANTANOL to LYSODREN Trade Name Generic GANTANOL Sulfamethoxazole GANTRISIN Sulfisoxazole GARAMYCIN Gentamicin GEOCILLIN Carbenicillin GLUCOPHAGE Metformin GLUCOTROL Glipizide GRIFULVIN V Griseofulvin GRISACTIN Griseofulvin HALCION Triazolam HALDOL Haloperidol HALDRONE Paramethasone HALOTESTIN...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, Factor IX concentrates to Itraconazole Trade Names of Some Commonly Used Drugs GENERIC AND TRADE NAMES OF COMMONLY USED DRUGS Factor IX concentrates to Itraconazole Generic Trade Name Factor IX concentrates KONYNE 80, PROPLEX T Famciclovir FAMVIR Famotidine PEPCID Felodipine PLENDIL Fenfluramine PONDIMIN Fenoprofen NALFON Fentanyl SUBLIMAZE Fexofenadine ALLEGRA Filgrastim NEUPOGEN Finasteride PROSCAR, PROPECIA Flavoxate...
Fainting: Low Blood Pressure: Merck Manual Home Edition Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
Diagnosis: Symptoms and Diagnosis of Heart and Blood Vessel Disorders: Merck Manual Home Edition Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, GANTANOL to LYSODREN Trade Names of Some Commonly Used Drugs TRADE AND GENERIC NAMES OF COMMONLY USED DRUGS GANTANOL to LYSODREN Trade Name Generic GANTANOL Sulfamethoxazole GANTRISIN Sulfisoxazole GARAMYCIN Gentamicin GEOCILLIN Carbenicillin GLUCOPHAGE Metformin GLUCOTROL Glipizide GRIFULVIN V Griseofulvin GRISACTIN Griseofulvin HALCION Triazolam HALDOL Haloperidol HALDRONE Paramethasone HALOTESTIN...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, Factor IX concentrates to Itraconazole Trade Names of Some Commonly Used Drugs GENERIC AND TRADE NAMES OF COMMONLY USED DRUGS Factor IX concentrates to Itraconazole Generic Trade Name Factor IX concentrates KONYNE 80, PROPLEX T Famciclovir FAMVIR Famotidine PEPCID Felodipine PLENDIL Fenfluramine PONDIMIN Fenoprofen NALFON Fentanyl SUBLIMAZE Fexofenadine ALLEGRA Filgrastim NEUPOGEN Finasteride PROSCAR, PROPECIA Flavoxate...
Reference Listed Drug Labeling Approved in February 2000 Erythromycin ethylsuccinate tab 50-297/S-018 Abbott 4 ERYPED Erythromycin ethylsuccinate oral susp 50-207/S-054 Abbott 4 NOVANTRONE Mitoxantrone hydrochloride inj 19-297/S-021 Immunex 4 PCE Erythromycin tab 50-611/S-018 Abbott 4 ACCOLATE Zafirlukast tab 20-547/S-011 Zeneca 7 ZESTRIL Lisinopril tab 19-777/S-037 Zeneca Pharms 7 GASTROCROM Cromolyn Na + oral sol 20-479/S-002 Medeva...
author: USERNAME
RLD LABELING APPROVED IN SEPTEMBER 1998 Reference Listed Drug Labeling Approved in September 1998 Some of the product names below contain links to the approved labeling or the supplemental approval letter describing the specific changes.- Click on the product name to view the approved labeling changes in Adobe Acrobat format
Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) Beta-Agonist Dosages BETA-AGONISTS MDI AEROSOL Albuterol (Proventil, Ventolin) 2-4 puffs q4h 0.5 cc (2.5 mg) in 2.5 cc NS Bitolterol (Tornalate) 2 puffs q8h 0.5 cc (0.2% [1 mg]) in 2 cc NS Isoetharine (Bronkosol) 4 puffs q4h 0.5 cc (0.25%) in 3 cc NS Isoproterenol (Isuprel) 5-15 puffs (1:200) q4h 0.5 cc (0.5%) in 3 cc NS Metaproterenol (Alupent, Metaprel) 2-3 puffs q3-4h...
http://www.fda.gov/cder/ogd/rld/10515S23.PDF page 1
author: CDER USER
http://www.fda.gov/cder/ogd/rld/11178s37.pdf page 8
http://www.fda.gov/cder/ogd/rld/11178s37.pdf page 7
http://www.fda.gov/cder/ogd/rld/11178s37.pdf page 6
http://www.fda.gov/cder/ogd/rld/11178s37.pdf page 5
http://www.fda.gov/cder/ogd/rld/11178s37.pdf page 4
http://www.fda.gov/cder/ogd/rld/11178s37.pdf page 1
http://www.fda.gov/cder/ogd/rld/10515s22.pdf page 3
